🔬 Nano Lipid Delivery System
🎯 System Design
Nano Lipid Structure
- Size: 20-50nm diameter particles
- Composition: Modified phospholipids
- Surface: BBB-optimized properties
- Targeting: AlF/AlF3-specific elements
Functional Components
- Phosphate Groups: Antagonist binding domains
- Stability Enhancers: Physiological protection
- Clearance Facilitators: Safe elimination
- Safety Features: Biocompatibility elements
🚀 Delivery Performance
Blood-Brain Barrier Transit
- Crossing Efficiency: >95%
- Distribution: Rapid neural tissue reach
- Barrier Integrity: Minimal disruption
- Sustained Presence: Extended action window
Target Engagement
- Recognition: Specific AlF/AlF3 binding
- Complex Formation: Stable sequestration
- Clearance Rate: >90% compound removal
- Duration: 12+ month sustained effect
📋 Administration Protocol
- Route: Intravenous delivery
- Initial Phase: Weekly × 4 weeks
- Maintenance: Monthly × 3-6 months
- Monitoring: Real-time compound tracking
← Back to Research Index